is diarrhea a symptom of glp 1 GI Adverse Effects Glucagon-Like Peptide-1 Receptor Agonists Weeks of Debilitating Symptoms': Mayim

Instead, maintain your current fiber level and increase it graduallyadd one high-fiber food per week rather than overhauling your diet overnight

In Apr26, Axsome has entered into an asset purchase agreement with Takeda for TAK-063 (balipodect), with an intention to develop it for treating schizophrenia & Tourette syndrome (P-III study-enabling activities for schizophrenia to begin in 2026) Total Revenue: $29.44B Founded Year: 1987 Total Employees: 17,000 Headquarters: California, United States Market Cap: $176.37B Stock Exchange: NASDAQ Gilead is a global biopharma company focused on antivirals and specialty therapeutics, with leadership in HIV, oncology, and liver diseases anchored by a strong antiviral franchise and an expanding oncology portfolio

Market Outlook and Strategic Insights The obesity and weight loss treatment landscape will undergo substantial transformation in the coming years

Increasing demand for obesity treatment therapies The growing demand for obesity treatment therapies is turning into a pretty big driver of growth in the global GLP-1 agonists market

The Harmony Outcomes trial further revealed that albiglutide reduced MACE by 22% over a median follow-up period of 1.6 years in patients with type 2 diabetes and cardiovascular disease ( p = 0.0006) [70]

Pfizer Inc